Neuroleukosis

Neuroleukemia is a group of rare and aggressive malignant neoplasms of the central nervous system. They are highly malignant tumors that affect the brain, spinal cord or their roots. Neuroleukemias can be caused by different types of leukemias, including chronic lymphocytic leukemia, prolymphocytic leukemia, and multiple myeloma. Neuroleukemia is characterized by a rapid onset, rapid progression and early appearance of neurological symptoms. In this article we will look at the main aspects of diagnosis, treatment and prognosis of the disease.

Definition of Neuroleukemia - rare and aggressive

Neuroleukemia is a condition that occurs when malignant cells grow and multiply in the nervous system. Malignant cells can invade the brain, spinal cord, and other parts of the nervous system such as nerves and ganglia.

Symptoms of neuroleukemia may include headaches, dizziness, fatigue, problems with memory and concentration, hallucinations and seizures. If you notice these symptoms, contact your doctor immediately. Neurolesciosis requires prompt treatment as it can lead to serious health consequences, including paralysis, brain damage and even death.

The causes of neuroleukemia have not been precisely established. However, some studies suggest that there is a link between neuroleukemia and certain types of blood cancers, such as lymphoma and leukopathy. It has also been discovered that certain viruses and infections can cause neuroleusciosis in humans.

Treatment of neuroleukomia depends on its type and stage of development. Combinations of chemotherapy, radiation therapy, and drugs that can reduce the growth of cancer cells are commonly used. An important stage of treatment is to prevent repeated relapses of the disease.